Pfizer's Avastin biosimilar wins FDA approval

Pfizer Inc said on Friday that the U.S. Food and Drug Administration had approved its biosimilar to Roche Holding AG's blockbuster cancer treatment Avastin.


from Reuters: Health News https://ift.tt/2RKjkll

Comments

Popular posts from this blog

Thunderstorms linked to rise in emergency room visits for respiratory problems